| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Blueprint Medicines Corp | Director | Common Stock | 8,412 | $757,080 | $90.00 | 21 Jun 2022 | Direct |
| Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 5,300 | $79,553 | $15.01 | 21 Jun 2022 | Direct |
| Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | 14 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 21 Jun 2022 | 4 | +$241 | 4 | Director | 30 Jun 2022, 21:53 |
| /report/000120919121056047-demetri-george-2021-09-14 | Translate Bio, Inc. | 14 Sep 2021 | 3 | $0 | 4 | Director | 14 Sep 2021, 19:25 |
| /report/000120919121056041-demetri-george-2021-09-14 | Translate Bio, Inc. | 14 Sep 2021 | 3 | $0 | 4 | Director | 14 Sep 2021, 19:20 |
| /report/000120919121040972-demetri-george-2021-06-16 | Translate Bio, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 17:13 |
| BPMC | Blueprint Medicines Corp | 02 Jun 2021 | 2 | $0 | 4 | Director | 04 Jun 2021, 16:18 |